Annual ROE
20.75%
-12.01%-36.66%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual return on equity is currently 20.75%, with the most recent change of -12.01% (-36.66%) on 31 December 2023. During the last 3 years, it has fallen by -37.55% (-64.41%). CPRX annual ROE is now -64.41% below its all-time high of 58.30%, reached on 31 December 2020.CPRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
27.81%
+12.88%+86.27%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly return on equity is currently 27.81%, with the most recent change of +12.88% (+86.27%) on 30 September 2024. Over the past year, it has increased by +8.76% (+45.98%). CPRX quarterly ROE is now -58.52% below its all-time high of 67.04%, reached on 30 September 2020.CPRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.7% | +46.0% |
| 3 y3 years | -64.4% | +19.3% |
| 5 y5 years | +140.2% | +80.9% |
CPRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.4% | at low | -26.8% | +86.3% |
| 5 y | 5 years | -64.4% | +140.2% | -58.5% | +86.3% |
| alltime | all time | -64.4% | +103.6% | -58.5% | +101.9% |
Catalyst Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 27.81%(+86.3%) |
| June 2024 | - | 14.93%(-8.0%) |
| Mar 2024 | - | 16.22%(-20.7%) |
| Dec 2023 | 20.75%(-36.7%) | 20.45%(+7.3%) |
| Sept 2023 | - | 19.05%(-49.9%) |
| June 2023 | - | 38.00%(+4.4%) |
| Mar 2023 | - | 36.40%(+8.5%) |
| Dec 2022 | 32.76%(+56.1%) | 33.54%(+14.0%) |
| Sept 2022 | - | 29.43%(+14.0%) |
| June 2022 | - | 25.81%(+13.8%) |
| Mar 2022 | - | 22.68%(+8.3%) |
| Dec 2021 | 20.98%(-64.0%) | 20.94%(-10.2%) |
| Sept 2021 | - | 23.31%(-49.7%) |
| June 2021 | - | 46.35%(-8.1%) |
| Mar 2021 | - | 50.45%(-15.9%) |
| Dec 2020 | 58.30%(+26.6%) | 60.01%(-10.5%) |
| Sept 2020 | - | 67.04%(+41.2%) |
| June 2020 | - | 47.49%(-16.0%) |
| Mar 2020 | - | 56.55%(+17.4%) |
| Dec 2019 | 46.06%(-189.2%) | 48.17%(+213.4%) |
| Sept 2019 | - | 15.37%(-176.8%) |
| June 2019 | - | -20.01%(-56.7%) |
| Mar 2019 | - | -46.19%(-6.8%) |
| Dec 2018 | -51.62%(+68.6%) | -49.55%(+29.0%) |
| Sept 2018 | - | -38.40%(+6.3%) |
| June 2018 | - | -36.11%(-2.7%) |
| Mar 2018 | - | -37.10%(-10.9%) |
| Dec 2017 | -30.62%(-19.7%) | -41.64%(-11.3%) |
| Sept 2017 | - | -46.96%(+9.4%) |
| June 2017 | - | -42.93%(+4.2%) |
| Mar 2017 | - | -41.21%(+7.0%) |
| Dec 2016 | -38.13%(-14.5%) | -38.53%(-0.0%) |
| Sept 2016 | - | -38.54%(+5.1%) |
| June 2016 | - | -36.66%(+7.4%) |
| Mar 2016 | - | -34.13%(-5.3%) |
| Dec 2015 | -44.61%(-18.6%) | -36.03%(+5.4%) |
| Sept 2015 | - | -34.18%(-10.2%) |
| June 2015 | - | -38.08%(-12.2%) |
| Mar 2015 | - | -43.35%(-15.0%) |
| Dec 2014 | -54.77% | -50.99%(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | -48.12%(-24.4%) |
| June 2014 | - | -63.63%(-24.9%) |
| Mar 2014 | - | -84.74%(+12.8%) |
| Dec 2013 | -67.50%(+52.2%) | -75.12%(-4.8%) |
| Sept 2013 | - | -78.93%(+10.7%) |
| June 2013 | - | -71.31%(+38.8%) |
| Mar 2013 | - | -51.36%(-7.0%) |
| Dec 2012 | -44.35%(-67.8%) | -55.23%(-54.5%) |
| Sept 2012 | - | -121.41%(+8.5%) |
| June 2012 | - | -111.85%(-19.0%) |
| Mar 2012 | - | -138.10%(+5.4%) |
| Dec 2011 | -137.76%(+125.8%) | -131.02%(+46.4%) |
| Sept 2011 | - | -89.52%(+12.1%) |
| June 2011 | - | -79.88%(+3.5%) |
| Mar 2011 | - | -77.17%(+13.6%) |
| Dec 2010 | -61.00%(-35.8%) | -67.94%(-1.7%) |
| Sept 2010 | - | -69.14%(-12.4%) |
| June 2010 | - | -78.90%(-6.1%) |
| Mar 2010 | - | -84.06%(-24.5%) |
| Dec 2009 | -95.06%(-5.0%) | -111.30%(-18.0%) |
| Sept 2009 | - | -135.70%(+14.0%) |
| June 2009 | - | -119.06%(+11.7%) |
| Mar 2009 | - | -106.63%(+32.2%) |
| Dec 2008 | -100.04%(+294.5%) | -80.66%(+51.1%) |
| Sept 2008 | - | -53.39%(+45.0%) |
| June 2008 | - | -36.83%(+36.6%) |
| Mar 2008 | - | -26.96%(+14.3%) |
| Dec 2007 | -25.36%(+84.4%) | -23.59%(+10.4%) |
| Sept 2007 | - | -21.36%(-29.9%) |
| June 2007 | - | -30.48%(-13.9%) |
| Mar 2007 | - | -35.40%(-3.0%) |
| Dec 2006 | -13.75%(-96.6%) | -36.50%(-88.3%) |
| Sept 2006 | - | -311.96%(-73.9%) |
| June 2006 | - | -1193.21%(+108.3%) |
| Mar 2006 | - | -572.86%(-11.3%) |
| Dec 2005 | -404.34%(-11.9%) | -646.18%(-55.3%) |
| Sept 2005 | - | -1444.30%(+6.7%) |
| June 2005 | - | -1353.40%(+49.3%) |
| Mar 2005 | - | -906.29%(+97.4%) |
| Dec 2004 | -459.01%(-19.5%) | -459.18% |
| Dec 2002 | -569.93% | - |
FAQ
- What is Catalyst Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual ROE year-on-year change?
- What is Catalyst Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly ROE year-on-year change?
What is Catalyst Pharmaceuticals annual return on equity?
The current annual ROE of CPRX is 20.75%
What is the all time high annual ROE for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual return on equity is 58.30%
What is Catalyst Pharmaceuticals annual ROE year-on-year change?
Over the past year, CPRX annual return on equity has changed by -12.01% (-36.66%)
What is Catalyst Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CPRX is 27.81%
What is the all time high quarterly ROE for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly return on equity is 67.04%
What is Catalyst Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CPRX quarterly return on equity has changed by +8.76% (+45.98%)